Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Gary J. Nabel files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Paul Peter Tak - $3.16M in CADL purchases and sales in the last 12 months
- Paul B. Manning - $3.00M in CADL purchases and sales in the last 12 months
- Francesca Barone - $236K in CADL purchases and sales in the last 12 months
- Seshu Tyagarajan - $154K in CADL purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Gary J. Nabel?
Gary J. Nabel is a corporate insider of Candel Therapeutics, Inc. (CADL). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Gary J. Nabel last file a Form 4?
The most recent primary Form 4 on record is dated 24 June 2026, one of 3 filings going back to 2025.
